Loqtorzi J Code: J3263

Drug & Product Overview

HCPCS Descriptor Injection, toripalimab-tpzi, 1 mg

HCPCS Added Date July 1, 2024

Manufacturer Coherus Biosciences, Inc

Route of Administration Intravenous

Generic Status Single-Source; Branded

Dosage Type Single-Dose

Dosage Form Injection

About Loqtorzi

Loqtorzi is a medication aligned to the HCPCS J Code: J3263 for billing, pricing, and reimbursement purposes in the United States. Classified under Antibiotic, it is administered via the intravenous route and manufactured by Coherus Biosciences, Inc.

According to CMS Drug Use Information: Toripalimab is used to treat a certain type of head and neck cancer (nasopharyngeal carcinoma). It works by changing the action of your own immune system, directing it to attack cancer cells. Toripalimab belongs to a class of drugs known as monoclonal antibodies.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
70114-0340-01	Loqtorzi	Coherus Oncology, Inc.	240	240 MG / 6 ML

Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

Loqtorzi Pricing & Reimbursement

J3263 Private Payer Reimbursement

$41.30 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q3 2026

Loqtorzi Claims Performance

Claims from Jan 2026 – Aug 2026

Claim Denial Rate 11.29%

Avg. Days to File 6.8days

Avg. Days to Pay 20.7days

Real-world claims performance from FocalPoint, OnPoint Oncology's reimbursement analytics platform, with claims data accrued at the clearing house level.

Explore J3263 claims analytics on FocalPoint →

Loqtorzi CPT Administration Codes

CPT Code	Description
96413	Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415	Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)

Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

Loqtorzi Medically Unlikely Edits (MUE)

The most billing units of J3263 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 mg.

Practitioner Office & Hospital Outpatient

480 units / day

= 480 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

Loqtorzi Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Nasopharyngeal carcinoma

Drug Class

Programmed Death Receptor-1 Blocking Antibody [EPC]Programmed Death Receptor-1-directed Antibody Interactions [MoA]

Frequently Asked Questions

Is there an available Loqtorzi billing and coding guide?

Billing and coding information for Loqtorzi can be found through Coherus Biosciences Inc. Visit Here →

Are there any available Loqtorzi patient assistance programs?

Loqtorzi patient assistance information can be found through Coherus Biosciences Inc. Visit Here →

Where can I find Loqtorzi prescribing information?

Loqtorzi prescribing information can be found at the link below: Visit Here →

Where can I find Loqtorzi side effect information?

Information regarding Loqtorzi's side effect information can be found at Medline Plus.

Does billing Loqtorzi require JZ/JW wastage modifiers?

CMS does not include Loqtorzi (J3263) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J3263. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.